1. Nurix Therapeutics Expands its Board of Directors with the Addition of Two Industry Leaders

    Nurix Therapeutics Expands its Board of Directors with the Addition of Two Industry Leaders

    SAN FRANCISCO, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a biopharmaceutical company developing targeted protein modulation drugs, today announced the appointments of Judith A. Reinsdorf and Paul M. Silva to its board of directors, effective October 1, 2021...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
  2. Quotes

    1. I am delighted to welcome Judy and Paul to the Nurix board as we enter this important stage in the company's development and execute on our plan to advance multiple programs into clinical trials by the end of 2021.
  3. Topics Mentioned

  4. Authors